Thyroid Cancer | Tumor

Precision Medicine and Clinical Trials

July 28th 2021, 2:04pm


Online resources available to patients with lung or thyroid cancer who are considering participation in a clinical trial after undergoing comprehensive genomic profiling.

Biomarker Testing: Centralized Vs Local Labs

July 28th 2021, 1:58pm


The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.

Access to Molecular Testing in the Community

July 21st 2021, 5:48pm


Current barriers that impact patient access to comprehensive biomarker testing in the community and efforts underway to help advocate for increased accessibility to molecular assays moving forward.

Becoming Informed About Comprehensive Genomic Profiling

July 21st 2021, 4:05pm


Resources available to support patients and community oncologists who are interested in learning more and gaining access to comprehensive biomarker testing.

Molecular Testing in Thyroid Cancer: Interpreting Results

June 23rd 2021, 2:06pm


Lori J. Wirth, MD, describes what information she looks for from results of molecular testing that help inform treatment for her patients with thyroid cancer.

Molecular Testing and Shared Decision-Making

June 23rd 2021, 1:58pm


Andrea Ferris, of the LUNGevity Foundation, explains why shared decision-making is important when recommending molecular testing to patients with lung or thyroid cancer and highlights resources provided through her organization that support patients and health care professionals.

Educating Patients About Biomarker Testing

June 16th 2021, 3:21pm


Common questions asked by patients with lung or thyroid cancer who have been referred for biomarker testing and advice for setting expectations from test results.

The Emerging Role of Liquid Biopsies

June 16th 2021, 3:15pm


Drs Benjamin Levy and Lori J. Wirth comment on the current role of liquid biopsies in lung and thyroid cancer.

Best Practices When Testing With Comprehensive Genomic Profiling

June 9th 2021, 2:45pm


Recommendations for selecting appropriate patients for comprehensive genomic profiling and navigating through the testing process.

Comprehensive Genomic Profiling in Lung and Thyroid Cancer

June 9th 2021, 2:35pm


Drs Benjamin Levy and Lori J. Wirth describe how they currently utilize comprehensive genomic profiling to manage patients with non–small cell lung cancer or thyroid cancer.